Approximately 3.2 million Americans suffering from cancer, heart disease, and other serious or life-threatening diseases benefit from home infusion therapy. As the name suggests, home infusion therapy ...

Longstanding Republican orthodoxy on free markets and scant details are making Trump’s drug pricing law push difficult.

Pharmaceutical giant Merck announced the cancellation of a planned $1.3 billion research center in London and the termination of all research and development activities in the United Kingdom (UK). The ...

Judged by its actions, the Trump Administration supports drug shortages. Clearly, this is not the President’s stated goal, but it is the inevitable result of his policies including his proposed drug ...

Here’s the breakdown on what’s really driving America’s runaway drug prices — and whether any of the current plans stand a chance to lower your pharmacy bill. When it comes to the sickening cost of ...

Cancer survival rates are on the rise, according to the American Cancer Society's latest annual report. Seven in 10 patients now live five years or more after a cancer diagnosis. Since 1991, ...

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 20 new drugs in its recent meeting, under the provisions of the Drugs Prices Control Order (DPCO), 2013, including ...

Some drug pricing reforms will leave independent practitioners under water, argue guest columnists Madelaine Feldman and ...

The authors argue that sustainable drug pricing reform should focus on patient-centered value, not price alone. IRP is a ...

The president can't just bring prices down with the stroke of his pen, no matter what he claimed in his State of the Union speech.

The proposed legislation would effectively set price controls on drugs, which jeopardizes the statewide life sciences industry, while not increasing affordability or access to medications.” — Stephen ...